electrophoretic deposition of nanostructured hydroxyapatite coating on az91 magnesium alloy implants...
TRANSCRIPT
![Page 1: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/1.jpg)
Accepted Manuscript
Title: Electrophoretic Deposition of NanostructuredHydroxyapatite Coating on AZ91 Magnesium Alloy Implantswith Different Surface Treatments
Author: Ramin Rojaee Mohammadhossein Fathi KeyvanRaeissi
PII: S0169-4332(13)01599-7DOI: http://dx.doi.org/doi:10.1016/j.apsusc.2013.08.108Reference: APSUSC 26251
To appear in: APSUSC
Received date: 14-5-2013Revised date: 19-8-2013Accepted date: 23-8-2013
Please cite this article as: R. Rojaee, M. Fathi, K. Raeissi, ElectrophoreticDeposition of Nanostructured Hydroxyapatite Coating on AZ91 Magnesium AlloyImplants with Different Surface Treatments, Applied Surface Science (2013),http://dx.doi.org/10.1016/j.apsusc.2013.08.108
This is a PDF file of an unedited manuscript that has been accepted for publication.As a service to our customers we are providing this early version of the manuscript.The manuscript will undergo copyediting, typesetting, and review of the resulting proofbefore it is published in its final form. Please note that during the production processerrors may be discovered which could affect the content, and all legal disclaimers thatapply to the journal pertain.
![Page 2: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/2.jpg)
Page 1 of 38
Accep
ted
Man
uscr
ipt
1
Electrophoretic Deposition of Nanostructured Hydroxyapatite Coating on AZ91 Magnesium 1
Alloy Implants with Different Surface Treatments2
Ramin Rojaee1*, Mohammadhossein Fathi1, 2, Keyvan Raeissi33
1Biomaterials Research Group, Department of Materials Engineering, Isfahan University 4of Technology, Isfahan, 84156-83111, Iran5
2Dental Materials Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.6
3Department of Materials Engineering, Isfahan University of Technology, Isfahan, 84156-83111, 7
Iran8
9
*Corresponding author, Tel.: +989119901024, Fax: +983113912752, E-mail: [email protected]
![Page 3: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/3.jpg)
Page 2 of 38
Accep
ted
Man
uscr
ipt
2
1
Abstract2
Bio-absorbable magnesium (Mg) based alloys have been introduced as innovative orthopedic3
implants during recent years. It has been specified that rapid degradation of Mg based alloys in 4
physiological environment should be restrained in order to be utilized in orthopedic trauma 5
fixation and vascular intervention. In this developing field of healthcare materials, micro-arc 6
oxidation (MAO), and MgF2 conversion coating were exploited as surface pre-treatment of 7
AZ91 magnesium alloy to generate a nanostructured hydroxyapatite (n-HAp) coating via 8
electrophoretic deposition (EPD) method. X-ray diffraction (XRD), Scanning Electron 9
Microscopy (SEM), Fourier Transform Infrared spectroscopy (FT-IR), and Transmission 10
Electron Microscopy (TEM) techniques were used to characterize the obtained powder and 11
coatings. The potentiodynamic polarization tests were carried out to evaluate the corrosion 12
behavior of the coated and uncoated specimens, and in vitro bioactivity evaluation were 13
performed in simulated body fluid. Results revealed that the MAO/n-HAp coated AZ91 Mg alloy 14
samples with a rough topography and lower corrosion current density leads to a lower Mg 15
degradation rate accompanied by high bioactivity.16
17
Keywords: Magnesium, Bio-degradable implant, Nanostructured hydroxyapatite, Electrophoretic18
deposition, Micro arc oxidation, Fluoride conversion coating.19
20
![Page 4: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/4.jpg)
Page 3 of 38
Accep
ted
Man
uscr
ipt
3
1
1. Introduction2
Metallic biomaterials compose major quota of orthopedic implants, nowadays. Prolonged 3
therapy and possible release of undesirable ions of conventional implants such as stainless steels 4
and cobalt–chromium alloys in body environment has demanded new bio-degradable/ bio-5
absorbable materials [1]. In this developing field of healthcare materials, magnesium alloys are 6
posed as potential bio-degradable/ bio-absorbable metallic implants. Although, an injured tissue 7
can consume Mg alloys implants during the healing period, the implants suffer from high 8
corrosion rate (i.e. high mass loss and abundant rate of hydrogen evolution) in body environment9
[2]. Therefore, further treatments should be fulfilled to increase the corrosion resistance of Mg 10
alloys, and consequently improve the hurt bone response to Mg alloys during post implantation11
[3]. Producing protective bioceramics coatings on Mg alloys would enhance their 12
biocompatibility and decelerate their degradation rate in physiological environments.13
Hydroxyapatite (HAp-Ca10(PO4)6OH2) is the main inorganic component of bones, which its 14
application as a coating provides advantages intimately attributed to its nanoscale structure15
[4,5]. Moreover, former investigations revealed that the nano-sized HAp can promote 16
mechanical properties, bone cell adhesion and proliferation within the injured area in comparison 17
with the micro-sized HAp [3]. Thus, it seems that applying the nanostructured HAp (n-HAp) on 18
Mg alloys give rise to a good bioactivity and superior corrosion resistance. Many methods are 19
utilized to coat bioceramics on metallic substrates. Among these, electrophoretic deposition 20
(EPD) seems to be more suitable to produce a homogeneous and dense ceramic, polymer and 21
composite coatings for biomedical applications [6]. In EPD technique, direct current (DC) is 22
applied to suspended powder particles in a liquid medium to charge the particles and deposit 23
![Page 5: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/5.jpg)
Page 4 of 38
Accep
ted
Man
uscr
ipt
4
them onto a conductive substrate of opposite charge [7]. Farrokhi-Rad and Ghorbani applied1
EPD technique to coat TiO2 nanoparticles on the 304 stainless steel and studied the 2
electrophoretic mobility of titania nanoparticles in different suspension mediums [8]. Mehdipour3
et al. deposited a kind of bioactive glass-contained Mg on 316L stainless steel via EPD to 4
improve the bioactivity of the substrate [9]. Besides, the biocompatibility of Mg-based alloy 5
surfaces could be improved via controlling their degradation rate utilizing fluoride conversion 6
coating and surface modification through micro arc oxidation (MAO) procedure [10,11].7
Fluoride conversion coatings are MgF2 layers produced by treating Mg substrate in hydrofluoric 8
acid (HF) [12]. Moreover, MAO technique is able to create a thick and stable porous ceramic 9
coating on Mg alloys [3]. The aim of this study was introduction of fluoride conversion coating 10
and MAO-produced layer as intermediate layers for n-HAp coating; also their effect on bio-11
corrosion behavior of these coating systems was investigated.12
2. Materials and methods13
2.1. Substrate surface preparation14
AZ91 magnesium alloy with chemical composition (wt. %) of 8.63 % Al, 0.59 % Zn, 0.17 %15
Mn, <0.05 % Fe, <0.05 % Cu and balance Mg was used as substrate. The as-cast AZ91 alloy was 16
heat-treated according to ASTM B661. AZ91 alloy samples were cut into dimensions of 20 mm17
× 10 mm × 2 mm. The surface roughness of both sides of the specimens was adjusted at Ra = 0.20 18
± 0.03 µm, using successive finer silicon carbide abrasive paper up to grit # 600. Then, the 19
specimens were ultrasonically cleaned (WUC-D10H, Wisd Laboratory Equipments, Germany) in 20
acetone for 30 min and dried quickly in warm stream of air.21
2.2. Fluoride conversion coating treatment22
![Page 6: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/6.jpg)
Page 5 of 38
Accep
ted
Man
uscr
ipt
5
For fluoride conversion treatment, the samples were immersed vertically in a plastic bottle 1
containing hydrofluoric acid 48 wt.% (HF, GR, Merck) at ambient temperature for 24 h [12]. 2
Then, the treated samples were rinsed by deionized water and dried in warm air.3
2.3. MAO coating procedure4
An aqueous saline solution electrolyte containing 100 g/l sodium hydroxide (NaOH) - 100 g/l5
sodium silicate (Na2SiO3) - 20 g/l potassium hydroxide (KOH) was provided as an anodizing6
solution. The composition of an anodizing bath was opted to induce Na, Si and K accompanied 7
with Mg and O elements into the surface of the AZ91 alloy samples. These elements are known 8
to be essential for metabolic processes and incorporating within the healing period [13].9
Plasma arc oxidation was performed under a constant applied voltage of 30V.cm-2 for 30 min. 10
Initial temperature of the anodizing solution was set at 25 ˚C. AZ91 magnesium alloy samples 11
were put as anodes (working) electrode and a stainless steel 316L sample was introduced as a 12
cathode (counter) electrode with the surface ratio of 1:1. The distance between the working and 13
counter electrodes was set 20 mm. The cell was connected to a DC power supply (IPC-14
SL20200J, 20 A, 200 V, Iran). After formation of anodic films, the samples were ultrasonically 15
rinsed with acetone and distilled water, and then dried in air.16
2.4. n-HAp powder preparation and coating17
2.4.1. n-HAp powder preparation18
n-HAp powders were synthesized using a simple sol-gel method [14]. For this purpose, calcium 19
nitrate tetrahydrate (Ca(NO3)2.4H2O, GR, Merck) and phosphorous pentoxide (P2O5, GR, 20
Merck) were dissolved separately in ethanol (C2H5OH, GR, Merck) as calcium (Ca) and 21
![Page 7: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/7.jpg)
Page 6 of 38
Accep
ted
Man
uscr
ipt
6
phosphorous (P) precursors, respectively. Ca-precursor was added drop-wise into the P-1
precursor. The mixture was continuously stirred for about 24 h at ambient temperature. The gel 2
was dried at 80 °C for 24 h in an oven (FN 120, NÜVE, Turkey). Then, the powders were heated 3
at a rate of 5 °C/min up to 600 °C in a muffle furnace (FHP 05, WiseTherm, Germany) and were 4
stored for 1 h at this temperature [14]. The synthesized powders were cooled to ambient 5
temperature. The heat-treated n-HAp powders were milled using a high-energy planetary ball 6
mill (PM 100, Retsch, Germany) with a zirconia vial and zirconia balls to produce more 7
homogenous n-HAp powders in the particle sizes. The ball milling parameters were selected as 8
follows: ball-to-powder weight ratio: 25:1, rotational speed: 250 rpm, and time: 5 h. Finally, this9
obtained powder was rinsed 3 times with ethanol and double distilled water in a centrifuge10
(EBA20,Hettich, Germany) at 6000 rpm each for 5 min to remove any impurities [15]. Finally, 11
powder was dried in oven at 80 ˚C for 5 h.12
2.4.2. Determination of particle dispersion stability13
In order to find the best pH for colloidal suspension used in EPD technique, the stability of 14
particles in a suspension as a function of pH was determined using a zeta potential-sizer 15
(ZEN3600, Malvern, England). The absolute values of zeta potential indicate the strength of 16
interactions among between colloidal particles and determines the degree of repulsion forces 17
among particles in a suspension [16,17]. Another important factor in determining the mobility of 18
the particles in a suspension is its electrical conductivity. It has been reported that too conductive 19
suspensions sustain very low particles motion and too resistive colloidal liquids would lost their 20
particles stability [7]. In the current study, the pH value has shown to impress the conductivity of 21
n-HAp suspension. Based on the zeta potential measurements, pH of the suspension was adjusted 22
using 0.1 mol/l nitric acid 65 wt. % (HNO3, GR, Merck) in order to obtain an stable suspension 23
![Page 8: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/8.jpg)
Page 7 of 38
Accep
ted
Man
uscr
ipt
7
condition for n-HAp powder deposition on AZ91 alloy samples. The pH values were monitored 1
by a pH meter (GLP 22+, Crison, Spain).2
2.4.3. n-HAp coating3
In order to provide an electrophoretic suspension medium, 50 g/l n-HAp powders were dispersed 4
in methanol (CH3OH, GR, Merck). It is worth noting that the purity degree of suspension is a 5
vital point. Incorporating humidity and water also causes hydrolyzing which produces H2 and O26
gases during coating procedure and provides a porous and non-homogenous deposition on the 7
substrate. The prepared suspension stirred at 400 rpm for 30 min at 25˚C in a beaker. The 8
suspension was ultrasonicated for 1 h to achieve a homogeneous dispersion of n-HAp particles. 9
Prior to EPD, the suspension was settled for 1 h to avoid deposition of flocculated particles. 10
Pristine AZ91 magnesium alloy, HF-treated and MAO-treated samples were used as the cathodes11
(negative charge). A graphite plate with 20mm×10mm×3mm dimensions was used as an anode 12
(positive charge). The distance between the cathode and the counter electrode was set to 20 mm. 13
n-HAp powders deposition was performed in two steps in order to achieve a more homogenous14
n-HAp coating. The stepwise deposition avoids any cracking during drying shrinkage as reported 15
before [17]. First deposition step was performed at a constant voltage of 50V.cm-2 for 3min. The 16
coated samples were kept at room temperature for 30 min for evaporating solvent of the coated 17
surface. Then, second coating step was deposited at constant voltage of 30 V.cm-2 for 5 min on 18
the previous layer to provide a dense n-HAp coating. Finally, the samples were put at ambient 19
temperature for drying.20
2.5. Characterization21
![Page 9: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/9.jpg)
Page 8 of 38
Accep
ted
Man
uscr
ipt
8
A monochromatic copper Kα radiation was selected for X-ray diffraction (XRD) studies, using a1
diffractometer (XRD, Philips Xpert, The Netherlands) operated at 40 kV and 30 mA at 2θ range 2
of 20˚– 60˚ at 0.02˚/s step size.3
Fourier transform-infrared spectroscopy (FTIR, Jasco-680, Japan) was utilized to identify and 4
confirm the functional groups of the coatings in the range of 2000–400 cm−1.5
Transmission electron microscopy (TEM, EMlOC Zeiss, Germany) was used to characterize the 6
synthesized hydroxyapatite nanoparticles. For this purpose, the samples were prepared by 7
dispersing the powders in ethanol. Then, the suspension was put in an ultrasonic bath for 30 min. 8
The prepared suspension was dropped on an amorphous carbon-coated copper grid for further 9
analysis.10
Scanning electron microscopy (SEM, Philips XL 30: Eindhoven, The Netherlands) equipped 11
with an energy dispersive X-ray spectroscopy (EDS, Seron Technology AIS 2300C, Korea) was12
used to study the microstructure and morphology of the coatings, distinguish the formation of 13
apatite sedimentation on the samples surface after immersion in biological testing environment, 14
and to determine the elemental distribution of the deposited coatings, respectively.15
2.6. Surface roughness measurement16
The surface roughness (Ra) of the treated samples were measured using a roughness tester 17
(Taylor-Hobson Surtronic Duo, Leicester, England) with a cut-off 0.8 mm. Five different 18
measurements were collected and the mean values and standard deviation were reported, 19
accordingly.20
2.7. In vitro bioactivity evaluation21
It is known that the bioactive materials can form bone-like apatite on their surfaces in an 22
acellular and protein-free simulated body fluid (SBF) having ion concentrations nearly equal to 23
![Page 10: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/10.jpg)
Page 9 of 38
Accep
ted
Man
uscr
ipt
9
those of human blood as produced in the living body [18]. The majority of bioactive implants1
bond to living bone through this apatite layer. It should be pointed out that the apatite 2
precipitates can bond to living bone through the apatite layer in the living body, as long as the 3
material does not contain any components that induces cytotoxic or antibody reactions. Despite 4
this constraints, investigation of apatite formation on the surface of a material in SBF is useful 5
for predicting the in vivo bone bioactivity behavior [19,20]. Several SBF compositions have 6
been proposed by Kokubo et al. [20]. However, these SBF procedures involve the risk of 7
premature precipitation of calcium phosphates [21]. Thus, in the following study, SBF was 8
prepared according to Bohner and Lemaitre [21] recipe in order to investigate the bioactivity 9
behavior of the coatings. This SBF preparation script is the revised procedure of Kokubo and 10
Takadama’s [20]. Table 1 indicates the SBF ions concentrations.11
Various groups of specimens with the effective surface area of 1 cm2 were incubated in SBF 12
solution and maintained in a water bath (NB9-NÜVE, Turkey) at 37±1 ˚C within 28 days in 13
order to investigate the precipitation of the apatite deposits on the samples.14
2.8. Evaluation of electrochemical corrosion behavior15
A tri-electrode cell set-up was used with a standard platinum electrode as a counter and an 16
Ag/AgCl (saturated with potassium chloride [KCl]) as a reference electrode. Each sample was17
immersed in 500 ml SBF solution at 37±1 ˚C and the atmosphere was open to air. The 18
potentiodynamic polarization tests were carried out after the samples were immersed in the test 19
solution for 1 h, so the electrode/solution interface reached a quasi-steady state in the electrolyte20
[22,23]. All the electrochemical measurements were carried out using an AMETEK21
potentiostat/galvanostat (PARSTAT 2273). The potentiodynamic polarization measurements 22
were monitored from -250 mV vs. OCP to 800 mV vs. Ag/AgCl with a scan rate of 1 mV/s. The 23
![Page 11: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/11.jpg)
Page 10 of 38
Accep
ted
Man
uscr
ipt
10
corrosion potentials (Ecorr.), corrosion current densities (iCorr.), anodic Tafel slopes (βa), and 1
cathodic Tafel slopes (βc) were extracted from the potentiodynamic polarization plots using Tafel 2
extrapolation and linear polarization methods [24].3
The polarization resistance (Rp) was calculated using the Stern–Geary equation according to 4
ASTM G59 (Eq. 1).5
2 303a c Corr . a cp iR / . ( ) (1)6
All the experiments were carried out at least three times and the mean values and standard 7
deviations were reported.8
3. Results and discussion9
3.1. Zeta potential/conductivity measurements10
The movement of ceramic particles in a suspension fluid is defined as the electrophoretic 11
mobility (µ) of the charged particles in a suspension [7]. This parameter is supported by the pH, 12
ionic strength and the viscosity of a suspension [17]. The electrophoretic mobility (µ) is defined 13
as Eq. 2 [17]. 14
µ = ζ.ε/4π.η (2)15
Where ζ, ε, η are the zeta potential, dielectric constant, and viscosity of the medium, respectively 16
[17]. As the methanol is chosen as a suspension medium for n-HAp deposition, ε and η could be 17
assumed almost constant. Thus, zeta potential is the main parameter in the particles’ mobility [7]. 18
It is worth noting that in the presence of DC electric field, the charged particles move in a 19
suspension toward the oppositely charged electrode [25]. The electrophoretic velocity (ν) is 20
given by the Eq. 3 [25].21
ν = E.µ (3)22
![Page 12: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/12.jpg)
Page 11 of 38
Accep
ted
Man
uscr
ipt
11
Where E is the potential gradient (V/cm), and µ is the electrophoretic mobility [25]. Eq. 3 shows 1
that a more electrophoretic velocity is attained in higher values of applied voltages.2
Fig. 1 shows the zeta potential and conductivity values of the suspension as a function of pH. It 3
can be seen that a higher zeta potential occurs at 4.5 <pH<6.5. Researchers reported that the 4
ionic strength of the suspension is closely dependent on the suspension conductivity [26]. As the 5
conductivity of a suspension increases, a larger amount of free ions will form in the suspension. 6
This phenomenon causes aggregation of colloidal particles and consequently, reduces the 7
mobility of particles [27]. Nevertheless, it has been found that a small amount of free ions in a 8
suspension acts as a electromotive force to move the particles towards an oppositely charged 9
electrode [27]. Thus, the optimum pH value of the present n-HAp suspension was fitted at 6.0, 10
where a higher zeta potential and also a suitable value of conductivity were monitored.11
3.2. Coating characterization12
3.2.1. X- ray diffraction and TEM studies13
Fig. 2 illustrates the X-ray diffraction pattern of pristine AZ91, MgF2 and MAO-treated AZ91 14
samples. As shown, pristine AZ91 microstructure is composed of α-phase (pure Mg), and β-15
phase (Al12Mg17). XRD pattern of MAO-coated sample indicates that it is mainly composed of 16
MgO, MgSiO3 and Mg2SiO4. Formation of these phases confirms that Mg, Si and O elements 17
were engaged in chemical reactions during MAO process [28]. Fig. 2 also confirms that the 18
fluoride treated sample is covered by MgF2 layer. The peaks of the substrate alloy are also 19
detected in the XRD pattern of coated samples.20
A typical X-ray diffraction pattern of n-HAp powder has been shown in Fig. 3. The crystallite 21
size of n-HAp powder was calculated using Scherrer’s equation [29,30]. The average crystallite 22
size was about 30 nm estimated from (002) diffraction peak. Fig. 4 shows TEM photomicrograph 23
![Page 13: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/13.jpg)
Page 12 of 38
Accep
ted
Man
uscr
ipt
12
of the n-HAp powder following the heat treatment at 600 ˚C. Morphology and size of the n-HAp 1
particles could be observed which confirms the nanocrystalline nature of the powder. The 2
average particle size of n-HAp powder was estimated to be about 45 nm in range.3
3.2.2. FT-IR spectroscopy analysis4
It is known that the peak positions in an infrared spectrum correlate with molecular composition 5
and structure [31]. Fig. 5 shows chemical composition of the n-HAp, MAO and MgF2-treated 6
samples obtained by FTIR spectra. A widened band relating to the vibration of adsorbed water is 7
observed between 1630-1640 cm-1 in n-HAp and MAO-treated samples (bending mode) [32]. 8
The IR signals in the range of 860-880 and 1400-1500 cm-1 indicate characteristic peaks of 9
carbonate phases and arise from the anti-symmetrical C-O stretching vibration and bending 10
resonance, respectively [32–34]. The peaks at 473 and 631 cm-1 are assigned to the stretching 11
modes of structural hydroxyl groups (O-H) in n-HAp lattice structure [29]. The bands at 572, 12
601, 1042 and 1089 cm-1 correspond to P-O bending vibration [30]. A peak around 962 cm-1 is 13
assigned to the PO43- tetrahedron stretching resonance [30]. On the other hand, a weak resonance 14
peak is detected at 424 cm-1in MAO-treated sample. This peak is attributed to Mg-O longitudinal 15
acoustic mode [35]. The characteristic stretching band related to SiO6 group is appeared at 68516
cm-1 indicating the presence of MgSiO3 in MAO-treated surface [36]. Also, the typical resonance 17
peaks of forsterite is observed at 903 and 1022 cm-1 indicating SiO4 stretching vibrations [37,38].18
With regard to MgF2-treated sample, the peak around 431 cm-1 is ascribed to Mg-F stretching 19
vibration [39]. It has been reported that MgF2 acts as a transparent layer against infrared 20
radiation in the range of 600–4000 cm-1, thus, it does not show further characteristic frequencies 21
[40]. Table 2 summarizes the FTIR results.22
3.2.3. SEM evaluation, surface and cross section studies23
![Page 14: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/14.jpg)
Page 13 of 38
Accep
ted
Man
uscr
ipt
13
Figs. 6- 8 show SEM micrographs and elemental analyses of the surface and cross section of the 1
MgF2, MAO, n-HAp layers formed on the substrate, respectively. Figs. 6a, b reveal formation of 2
a dense and uniform layer of MgF2 with a mean thickness of 1.31 ± 0.02 μm. The average surface 3
roughness of this layer was 0.23 ± 0.01 μm. Fig. 6c shows the elemental analysis and maps of 4
elemental distribution for fluoride-treated surface. O, F, Mg and Al elements were detected in 5
this structure. It is worth noting that Al and Mg are mainly originated from the substrate.6
Fig.7 shows the typical SEM micrograph of surface and cross section of MAO layer on AZ91 7
sample. As is seen, the surface is consisted of several circular pores arise due to the 8
inhomogeneous growing pattern of the coating and trapping of molten oxide and gas bubbles 9
during the coating growth process [1,41]. This event caused a porous outer layer with 2–5 μm in 10
diameter accompanied with a dense inner layer. The average surface roughness of MAO-treated 11
surface was assessed 2.22 ± 0.05 μm and the mean thickness of MAO layer was 21.11 ± 2.51 μm.12
The corresponding EDS surficial elemental analysis and scanning map of the MAO layer13
confirm the distribution of O, Na, Mg, Si, and K elements within the structure. The presence of 14
these elements in MAO layer suggests that they were incorporated into the surface structure 15
during anodizing process [3].16
Fig. 8 shows the SEM surface morphology and the cross sections of n-HAp coated samples at the 17
opted conditions as described in section 2.5. The n-HAp coatings were consisted of an outer 18
course layer with the mean thicknesses of 87.31 ± 4.52 μm on the MAO (Fig. 8b) and 82.67 ± 19
1.33 μm on the MgF2 (Fig. 8c) intermediate layers. The n-HAp coating showed an average 20
roughness of 5.05 ± 0.72 µm in the both cases. Previously, Deligianni et al. [42] stated that the 21
roughness of hydroxyapatite surface affects cellular response, and has a direct effect on 22
enhancing cell adhesion and proliferation. EDS pattern of n-HAp coating is shown in Fig. 8d. 23
![Page 15: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/15.jpg)
Page 14 of 38
Accep
ted
Man
uscr
ipt
14
Quantitative estimation of atomic percentages in EDS analysis and pre-calculated Ca/P ratio1
(“34.1:18.88” vs. “1.67:1”) was in the same range, showing that Ca, P-precursors were 2
incorporated completely during n-HAp production reaction.3
3.3. Corrosion behavior evaluation4
Fig. 9 illustrates typical potentiodynamic polarization curves of MgF2 and MAO-treated AZ915
alloy (with and without n-HAp coating) in SBF solution, and pristine AZ91 as control specimen.6
The average values of electrochemical parameters were extracted and could be observed in Table 7
3. It can be seen that (i) all types of the coatings (MgF2, MgF2/n-HAp, MAO, MAO/n-HAp)8
ennobled the corrosion potential. This could be a good indication of the coating stability [43]; (ii) 9
all types of the coatings decreased the substrate corrosion current density, significantly. There is 10
no significant difference between the corrosion current densities of MgF2 and MgF2/n-HAp or 11
MAO and MAO/n-HAp samples. However, it should be remarked that the major role of the n-12
HAp coating was enhancing the surface bioactivity. While, it could be seen that it also improved13
the corrosion resistance in some extent; (iii) the slope of anodic branch is much steeper for all 14
types of the coated samples comparing AZ91 substrate. This could be a response of the higher 15
activation energy in releasing Mg2+ ions, causing lower corrosion rates [44]; (iv) Rp is one of the 16
most important variables in direct proportion to the corrosion resistance [45]. Rp measurements 17
demonstrate that the interlayers lead to significant increase in the corrosion resistance, i.e. the 18
MgF2 and MAO layers can provide good barriers against the substrate rapid degradation.19
Consequently, it is considerable that the interlayers also play an important role in improvement 20
of the biocompatibility of AZ91 alloy [46].21
3.4. In vitro bioactivity responses22
![Page 16: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/16.jpg)
Page 15 of 38
Accep
ted
Man
uscr
ipt
15
One of the most efficient parameters in governing the bioactivity of materials is to investigate the 1
precipitation behavior of bone-like apatites on their surface [47]. The bioactivity process will 2
take place at the material periphery via releasing and adsorbing ions [48]. Thus, different 3
coatings show different morphology of the precipitated apatites [49]. The surface morphology of 4
the coatings following immersion within 4 weeks in SBF solution was observed with SEM, and 5
are represented in Fig. 10. Pristine AZ91 sample was also immersed in the same solution for 6
comparison. It can be seen that the semi-spherical crystals of apatite-like precipitations had been 7
deposited densely on the pristine AZ91 sample (Fig. 10a). Since the precipitations removed from 8
the surface, micro-pits were observed on the surface (red circles in the Fig. 10b). Fig. 10c shows9
the fluoride-treated surface after soaking in SBF solution. The surface presented a crackled 10
appearance due to the incorporation of the interlayer’s ions (Mg2+, F-) in mineralization process11
[49]. It is worth noting that a low density of bone-like apatite crystals formed on MgF2 surface.12
This could be due to the presence of fluorine in the coating which decreases the bio-absorbability 13
of calcium phosphates in SBF solution [50]. Previously, Yan et al. [45] and Zahrani et al. [50]14
have reported a similar behavior of apatite sedimentations on fluoridated coatings. Fig. 10d15
represents the apatite precipitations on MgF2/n-HAp surface. By comparing Fig. 10c and Fig. 16
10d, it could be deduced that n-HAp coating on MgF2 layer was able to speed up the apatite 17
sedimentation reaction compared to that happens on MgF2 layer. Thus, more precipitation 18
occurs.19
Figs. 10e and 10f demonstrate the behavior of the surface bioactivity on MAO-treated surface 20
and MAO/n-HAp coating, respectively. Both MAO and MAO/n-HAp coated surfaces were 21
covered with dense apatite precipitations. This indicates that they are highly prone to induce 22
precipitation of bone-like apatites and stimulate matrix mineralization. Presence of several ions 23
![Page 17: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/17.jpg)
Page 16 of 38
Accep
ted
Man
uscr
ipt
16
within the surface would enhance the bone-forming ability of implant materials [13]. Moreover, 1
by the higher the surface roughness (n-HAp>MAO>MgF2), greater bioactivity occurs [51]. The2
morphology and condition of the precipitated bone-like apatites can be observed in Fig. 10.3
Combining the results of immersion test and potentiodynamic polarization measurements4
conducted that the best bioactivity and corrosion resistance for MAO/n-HAp coating in SBF5
solution. It can be concluded that this type of coating system (n-HAp layer as a top-coat and 6
MAO layer as an inter-layer) can provide a suitable framework for cell adhesion, encouraging 7
growth and stable healing due to its surface roughness which also has the benefits of controlled 8
Mg2+ ion release from the substrate.9
4. Conclusion10
The present literature introduced the MgF2 and MAO coatings as the inter-layers between AZ91 11
alloy substrate and n-HAp bioceramic top-coat. Presence of several ions within the coat layer 12
provides promising agents necessary for enhancing the bone-forming ability of implant 13
materials. Higher corrosion resistance of the MAO/n-HAp coated sample led to the tailored 14
degradation kinetics of AZ91 alloy substrate as biodegradable implants. Moreover, its rough 15
surface also plays an effective role in the healing process. The presented data support the 16
research that the MAO/n-HAp coating is highly prone to be utilized on Mg-based bio-absorbable 17
metallic implants that offer improved patient outcomes.18
Acknowledgements19
The authors are grateful for support of this research by Biomaterials Research Group of Isfahan 20
University of Technology.21
22
![Page 18: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/18.jpg)
Page 17 of 38
Accep
ted
Man
uscr
ipt
17
1
References2
[1] W. Li, S. Guan, J. Chen, J. Hu, S. Chen, L. Wang, et al., Preparation and in vitro degradation 3of the composite coating with high adhesion strength on biodegradable Mg–Zn–Ca alloy, 4Mater. Charact. 62 (2011) 1158–1165.5
[2] M. Bornapour, N. Muja, D. Shum-Tim, M. Cerruti, M. Pekguleryuz, Biocompatibility and 6biodegradability of Mg-Sr alloys: the formation of Sr-substituted hydroxyapatite., Acta 7Biomater. 9 (2013) 5319–5330.8
[3] J.H. Gao, S.K. Guan, J. Chen, L.G. Wang, S.J. Zhu, J.H. Hu, et al., Fabrication and 9characterization of rod-like nano-hydroxyapatite on MAO coating supported on Mg–Zn–10Ca alloy, Appl. Surf. Sci. 257 (2011) 2231–2237.11
[4] N. Degirmenbasi, D.M. Kalyon, E. Birinci, Biocomposites of nanohydroxyapatite with 12collagen and poly(vinyl alcohol)., Colloids Surf., B. 48 (2006) 42–49.13
[5] E. Peon, G. Fuentes, J.A. Delgado, L. Morejon, A. A., R. García, Preparation and 14characterization of porous blocks of synthetic hydroxyapatite, Latin. Am. Appl. Res. 34 15(2004) 225–228.16
[6] F. Gebhardt, S. Seuss, M.C. Turhan, H. Hornberger, S. Virtanen, A.R. Boccaccini, 17Characterization of electrophoretic chitosan coatings on stainless steel, Mater. Lett. 66 18(2012) 302–304.19
[7] L. Besra, M. Liu, A review on fundamentals and applications of electrophoretic deposition 20(EPD), Prog. Mater Sci. 52 (2007) 1–61.21
[8] M. Farrokhi-Rad, M. Ghorbani, Electrophoretic Deposition of Titania Nanoparticles in 22Different Alcohols: Kinetics of Deposition, J. Am. Ceram. Soc. 94 (2011) 2354–2361.23
[9] M. Mehdipour, A. Afshar, M. Mohebali, Electrophoretic deposition of bioactive glass coating 24on 316L stainless steel and electrochemical behavior study, Appl. Surf. Sci. 258 (2012)259832-9839.26
[10] J.-H. Jo, B.-G. Kang, K.-S. Shin, H.-E. Kim, B.-D. Hahn, D.-S. Park, et al., Hydroxyapatite 27coating on magnesium with MgF2 interlayer for enhanced corrosion resistance and 28biocompatibility., J. Mater. Sci. - Mater. Med. 22 (2011) 2437–2447.29
[11] J. Wang, J. Tang, P. Zhang, Y. Li, J. Wang, Y. Lai, et al., Surface modification of 30magnesium alloys developed for bioabsorbable orthopedic implants: A general review., J. 31Biomed. Mater. Res. Part B. 100 (2012) 1691–701.32
![Page 19: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/19.jpg)
Page 18 of 38
Accep
ted
Man
uscr
ipt
18
[12] K.Y. Chiu, M.H. Wong, F.T. Cheng, H.C. Man, Characterization and corrosion studies of 1fluoride conversion coating on degradable Mg implants, Surf. Coat. Technol. 202 (2007) 2590–598.3
[13] A. Hoppe, N.S. Güldal, A.R. Boccaccini, A review of the biological response to ionic 4dissolution products from bioactive glasses and glass-ceramics., Biomaterials. 32 (2011) 52757–2774.6
[14] M.H. Fathi, A. Hanifi, Evaluation and characterization of nanostructure hydroxyapatite 7powder prepared by simple sol–gel method, Mater. Lett. 61 (2007) 3978–3983.8
[15] Y. Liu, W. Wang, Y. Zhan, C. Zheng, G. Wang, A simple route to hydroxyapatite 9nanofibers, Mater. Lett. 56 (2002) 496–501.10
[16] A. Doostmohammadi, A. Monshi, R. Salehi, M.H. Fathi, Z. Golniya, A.U. Daniels, 11Bioactive glass nanoparticles with negative zeta potential, Ceram. Int. 37 (2011) 2311–122316.13
[17] C. Wang, J. Ma, W. Cheng, R. Zhang, Thick hydroxyapatite coatings by electrophoretic 14deposition, Mater. Lett. 57 (2002) 99–105.15
[18] T. Kokubo, Design of bioactive bone substitutes based on biomineralization process, Mater. 16Sci. Eng., C. 25 (2005) 97–104.17
[19] T. Kokubo, S. Yamaguchi, Bioactive Layer Formation on Metals and Polymers, in: 18Comprehensive Biomaterials, Elsevier Ltd., 2011: pp. 231–244.19
[20] T. Kokubo, H. Takadama, How useful is SBF in predicting in vivo bone bioactivity?, 20Biomaterials. 27 (2006) 2907–2915.21
[21] M. Bohner, J. Lemaitre, Can bioactivity be tested in vitro with SBF solution?, Biomaterials. 2230 (2009) 2175–2179.23
[22] M. Fathi, A. Doostmohammadi, Preparation and characterization of sol–gel bioactive glass 24coating for improvement of biocompatibility of human body implant, Mater. Sci. Eng., A. 25474 (2008) 128–133.26
[23] W. Wang, F. Mohammadi, A. Alfantazi, Corrosion behaviour of niobium in phosphate 27buffered saline solutions with different concentrations of bovine serum albumin, Corros. 28Sci. 57 (2012) 11–21.29
[24] M. Fathi, M. Salehi, A. Saatchi, V. Mortazavi, S. Moosavi, In vitro corrosion behavior of 30bioceramic, metallic, and bioceramic-metallic coated stainless steel dental implants, 31Dental Materials. 19 (2003) 188–198.32
![Page 20: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/20.jpg)
Page 19 of 38
Accep
ted
Man
uscr
ipt
19
[25] J.H. Kennedy, A. Foissy, Measurement of Mobility and Zeta Potential of Beta-Alumina 1Suspensions in Various Solvents, J. Am. Ceram. Soc. 60 (1977) 33–36.2
[26] A.A. Abdeltawab, M.A. Shoeib, S.G. Mohamed, Electrophoretic deposition of 3hydroxyapatite coatings on titanium from dimethylformamide suspensions, Surf. Coat. 4Technol. 206 (2011) 43–50.5
[27] J. Ma, C. Wang, K.W. Peng, Electrophoretic deposition of porous hydroxyapatite scaffold, 6Biomaterials. 24 (2003) 3505–3510.7
[28] L. Zhao, C. Cui, Q. Wang, S. Bu, Growth characteristics and corrosion resistance of micro-8arc oxidation coating on pure magnesium for biomedical applications, Corros. Sci. 52 9(2010) 2228–2234.10
[29] M. Fathi, A. Hanifi, V. Mortazavi, Preparation and bioactivity evaluation of bone-like 11hydroxyapatite nanopowder, J. Mater. Process. Technol. 202 (2008) 536–542.12
[30] R. Panda, M. Hsieh, R. Chung, T.S. Chin, FTIR, XRD, SEM and solid state NMR 13investigations of carbonate-containing hydroxyapatite nano-particles synthesized by 14hydroxide-gel technique, J. Phys. Chem. Solids. 64 (2003) 193–199.15
[31] B.C. Smith, Fundamentals of Fourier Transform Infrared Spectroscopy, second ed., Taylor 16and Francis Group, New York, 2011.17
[32] E. Mohammadi Zahrani, M.H. Fathi, A.M. Alfantazi, Sol-Gel Derived Nanocrystalline 18Fluoridated Hydroxyapatite Powders and Nanostructured Coatings for Tissue Engineering 19Applications, Metall. Mater. Trans. A. 42 (2010) 3291–3309.20
[33] R. Willumeit, J. Fischer, F. Feyerabend, N. Hort, U. Bismayer, S. Heidrich, et al., Chemical 21surface alteration of biodegradable magnesium exposed to corrosion media., Acta 22Biomater. 7 (2011) 2704–2715.23
[34] Y. Zhao, M. Song, J. Liu, Characteristics of bioactive glass coatings obtained by pulsed 24laser deposition, Surf. Interface Anal. 40 (2008) 1463–1468.25
[35] A.M. Hofmeister, E. Keppel, A.K. Speck, Absorption and reflection infrared spectra of 26MgO and other diatomic compounds, Mon. Not. R. Astron. Soc. 345 (2003) 16–38.27
[36] Q. Williams, Vibrational spectrum of MgSiO3 perovskite: zero-pressure Raman and mid-28infrared spectra to 27 GPa, J. Geophys. Res. 92 (1987) 8116–8128.29
[37] M. Kharaziha, M.H. Fathi, Synthesis and characterization of bioactive forsterite 30nanopowder, Ceram. Int. 35 (2009) 2449–2454.31
![Page 21: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/21.jpg)
Page 20 of 38
Accep
ted
Man
uscr
ipt
20
[38] B.J. Saikia, G. Parthasarathy, Fourier Transform Infrared Spectroscopic Characterization of 1Kaolinite from Assam and Meghalaya, Northeastern India, J. Mod. Phys. 01 (2010) 206–2210.3
[39] A. Saberi, Z. Negahdari, S. Bouazza, M. Willert-Porada, Synthesis and characterization of 4crystalline nanosized MgF2 powder via microemulsion route, J. Fluorine Chem. 131 5(2010) 1353–1355.6
[40] M. Wojciechowska, M. Zieliński, M. Pietrowski, MgF2 as a non-conventional catalyst 7support, J. Fluorine Chem. 120 (2003) 1–11.8
[41] H. Guo, M. An, S. Xu, H. Huo, Microarc oxidation of corrosion resistant ceramic coating on 9a magnesium alloy, Mater. Lett. 60 (2006) 1538–1541.10
[42] D.D. Deligianni, N.D. Katsala, P.G. Koutsoukos, Y.F. Missirlis, Effect of surface roughness 11of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and 12detachment strength, Biomaterials. 22 (2000) 87–96.13
[43] V. Barranco, N. Carmona, J.C. Galván, M. Grobelny, L. Kwiatkowski, M.A. Villegas, 14Electrochemical study of tailored sol–gel thin films as pre-treatment prior to organic 15coating for AZ91 magnesium alloy, Prog. Org. Coat. 68 (2010) 347–355.16
[44] R. Rojaee, M.H. Fathi, K. Raeissi, Controlling the Degradation Rate of AZ91 Magnesium 17Alloy via Sol-Gel Derived Nanostructured Hydroxyapatite Coating, Mater. Sci. Eng., C. 1833 (2013) 3817–3825.19
[45] T. Yan, L. Tan, D. Xiong, X. Liu, B. Zhang, K. Yang, Fluoride treatment and in vitro 20corrosion behavior of an AZ31B magnesium alloy, Mater. Sci. Eng., C. 30 (2010) 740–21748.22
[46] L. Tan, Q. Wang, F. Geng, X. Xi, J. Qiu, K. Yang, Preparation and characterization of Ca-P 23coating on AZ31 magnesium alloy, T. Nonferr. Metal. Soc. 20 (2010) s648–s654.24
[47] M. Kheradmandfard, M.H. Fathi, M. Ahangarian, E.M. Zahrani, In vitro bioactivity 25evaluation of magnesium-substituted fluorapatite nanopowders, Ceram. Int. 38 (2012) 26169–175.27
[48] E. Jallot, J.M. Nedelec, A.S. Grimault, E. Chassot, A. Grandjean-Laquerriere, P. 28Laquerriere, et al., STEM and EDXS characterisation of physico-chemical reactions at the 29periphery of sol-gel derived Zn-substituted hydroxyapatites during interactions with 30biological fluids., Colloids Surf., B. 42 (2005) 205–210.31
[49] Q. Zhang, J. Chen, J. Feng, Y. Cao, C. Deng, X. Zhang, Dissolution and mineralization 32behaviors of HA coatings, Biomaterials. 24 (2003) 4741–4748.33
![Page 22: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/22.jpg)
Page 21 of 38
Accep
ted
Man
uscr
ipt
21
[50] E. Mohammadi Zahrani, M.H. Fathi, The effect of high-energy ball milling parameters on 1the preparation and characterization of fluorapatite nanocrystalline powder, Ceram. Int. 35 2(2009) 2311–2323.3
[51] B.D. Boyan, R. Batzer, K. Kieswetter, Y. Liu, D.L. Cochran, S. Szmuckler-Moncler, et al., 4Titanium surface roughness alters responsiveness of MG63 osteoblast-like cells to 1α,25-5(OH)2D3, J. Biomed. Mater. Res. Part A. 39 (1998) 77–85.6
[52] B.A. Kolesov, J.V. Tanskaya, Raman spectra and cation distribution in the lattice of 7olivines, Mater. Res. Bull. 31 (1996) 1035–1044.8
9
![Page 23: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/23.jpg)
Page 22 of 38
Accep
ted
Man
uscr
ipt
22
1
Legend of Figures2
Fig. 1. Zeta potential/conductivity of a n-HAp/methanol suspension as a function of pH.3
Fig. 2. XRD patterns of pristine AZ91alloy, MgF2 and MAO coatings.4
Fig. 3. XRD pattern of sol–gel derived n-HAp powder after heating at 600 ˚C for 1 h.5
Fig. 4. TEM micrograph of sol–gel derived n-HAp powder after heating at 600 ˚C for 1 h.6
Fig. 5. FTIR spectra of the MgF2, MAO and n-HAp coatings.7
Fig. 6. Morphologies of; (a) the surface, (b) cross section, (c) elemental compositions at the 8
selected area quantified by EDS analysis and corresponding element distribution images of 9
fluoride-treated AZ91 alloy.10
Fig. 7. Morphologies of; (a) surface, (b) cross section, (c) elemental compositions at the selected 11
area quantified by EDS analysis and corresponding element distribution images of MAO-treated 12
AZ91 alloy.13
Fig. 8. Morphologies of; (a) the surface of the n-HAp coating, (b) cross section of the MAO/n-14
HAp coating, (c) cross section of the MgF2/n-HAp coating, (d) and elemental compositions at the 15
selected area quantified by EDS analysis of the n-HAp coating.16
Fig. 9. Electrochemical corrosion polarization curves of (a) the pristine AZ91, and the samples 17
treated with; (b) MgF2 coating, (c) MgF2/n-HAp coating, (d) MAO coating, and (e) MAO/n-HAp18
coating.19
![Page 24: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/24.jpg)
Page 23 of 38
Accep
ted
Man
uscr
ipt
23
Fig. 10. SEM photomicrographs of the surface of (a) the pristine AZ91, (b) the pristine AZ91 1
after removing precipitations and corrosion products, (c) MgF2 coating, (d) MgF2/n-HAp2
coating, (e) MAO coating, and (f) MAO/n-HAp coating, after 28 days soaking in the SBF.3
![Page 25: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/25.jpg)
Page 24 of 38
Accep
ted
Man
uscr
ipt
24
1
Table 1. Nominal ion concentrations of SBF in comparison with those in human blood plasma [21].2
3
4
5
6
7
8
9
10
11
12
Ion concentrations (mM)
Blood plasma SBF
Na+ 142.0 142.0
K+ 5.0 5.0
Mg2+ 1.5 1.5
Ca2+ 2.5 2.5
HCO3- 27.0 4.2
HPO42- 1.0 1.0
SO42- 0.5 0.5
Cl- 103.0 147.96
pH 7.2-7.4 ≈7.4
![Page 26: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/26.jpg)
Page 25 of 38
Accep
ted
Man
uscr
ipt
25
1
Table 2. Infrared band positions of the studied samples.2
3
Wavenumber (cm-1)n-HApcoating
MAOcoating
MgF2
coatingAssignment References
--- 424 --- Mg-O (longitudinal acoustic) [35]--- --- 431 Mg-F (stretching) [39,40]
473 --- --- O-H (stretching) [29]572 --- --- P-O (bending) [30]601 --- --- P-O (bending) [30]631 --- --- O-H (stretching) [29]--- 685 --- Si-O (stretching) [36]
876 865 --- C-O (bending) [32,34]--- 903 --- Si-O (stretching) [37,52]
962 --- --- P-O (stretching) [30]--- 1022 --- Si-O (stretching) [38]
1042 --- --- P-O (bending) [30]1089 --- --- P-O (bending) [30]1432 1411 --- C-O (anti-symmetrical stretching) [33]1457 1453 --- C-O (anti-symmetrical stretching) [33]1633 1631 --- H-O-H (bending) [32]
![Page 27: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/27.jpg)
Page 26 of 38
Accep
ted
Man
uscr
ipt
26
1
Table 3. Electrochemical data related to potentiodynamic polarization curves.2
Samples Ecorr., mV icorr., µA/cm2 Βa, mV/dec Βc, mV/dec Rp, Ω/cm2
Pristine AZ91 -1448 (51) 22.14 (3.21) 30 (4) 120 (6) 471
MgF2 coated AZ91 -1371 (50) 7.36 (0.63) 104 (5) 486 (31) 5 × 103
MgF2/n-HAp coated AZ91 -1400 (24) 2.92 (0.71) 75 (8) 506 (34) 9.7 × 103
MAO coated AZ91 -1280 (30) 0.58 (0.01) 83 (6) 125 (4) 3.7 × 104
MAO/n-HAp coated AZ91 -1323 (28) 0.45 (0.05) 96 (6) 141 (8) 5.5 × 104
3
4
![Page 28: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/28.jpg)
Page 27 of 38
Accep
ted
Man
uscr
ipt
27
Research highlights1
Nano-hydroxyapatite (n-HAp) particles synthesized using a sol-gel process.2
Stable suspension of n-HAp powders was prepared in methanol medium.3
Fluoride and MAO pre-treatments were applied on AZ91 samples as intermediate layers.4
Electrophoretic deposition process was used for coating n-HAp particles.5
The MAO/n-HAp/AZ91 system is highly prone to be utilized as bio-absorbable implants.6
7
![Page 29: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/29.jpg)
Page 28 of 38
Accep
ted
Man
uscr
ipt
Graphical Abstract (for review)
![Page 30: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/30.jpg)
Page 29 of 38
Accep
ted
Man
uscr
ipt
Figure1
![Page 31: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/31.jpg)
Page 30 of 38
Accep
ted
Man
uscr
ipt
Figure2
![Page 32: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/32.jpg)
Page 31 of 38
Accep
ted
Man
uscr
ipt
Figure3
![Page 33: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/33.jpg)
Page 32 of 38
Accep
ted
Man
uscr
ipt
Figure4
![Page 34: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/34.jpg)
Page 33 of 38
Accep
ted
Man
uscr
ipt
Figure5
![Page 35: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/35.jpg)
Page 34 of 38
Accep
ted
Man
uscr
ipt
Figure6
![Page 36: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/36.jpg)
Page 35 of 38
Accep
ted
Man
uscr
ipt
Figure7
![Page 37: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/37.jpg)
Page 36 of 38
Accep
ted
Man
uscr
ipt
Figure8
![Page 38: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/38.jpg)
Page 37 of 38
Accep
ted
Man
uscr
ipt
Figure9
![Page 39: Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments](https://reader030.vdocuments.site/reader030/viewer/2022020103/575095811a28abbf6bc2685a/html5/thumbnails/39.jpg)
Page 38 of 38
Accep
ted
Man
uscr
ipt
Figure10